Deep brain stimulation (DBS) is more effective at easing nonmotor symptoms and improving life quality for people with the…
Joana Vindeirinho, PhD
Joana is a Science Writer at BioNews. She is a cell biologist with a PhD in neurobiology of disease (University of Coimbra, Portugal), focused on the role of the adenosinergic system in the early stages of diabetic retinopathy. She moved from research into high-impact medical editing in 2017, before shifting into a more direct science writing and communication role in 2022.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Joana Vindeirinho, PhD
People with Parkinson’s disease have a nearly twofold higher risk of developing osteoporosis, a chronic condition marked by increased…
Scientists have identified potential biomarkers for the early detection of Parkinson’s disease in certain people carrying a common disease…
Suppressing the activity of carnitine palmitoyl-transferase 1 (CPT1) — a key enzyme in the metabolism of fatty molecules — led…
Combining Myrbetriq (mirabegron) with modifications like pelvic floor exercises failed to ease overactive bladder symptoms in people with Parkinson’s…
ABBV-951, a continuous infusion formulation of levodopa/carbidopa that’s administered under the skin, improved “on” time and decreased “off” time when…
The small molecule anle138b, an experimental therapy for Parkinson’s disease, was shown in a study to bind to lipidic (fat)…